Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 136-144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA)

By Karamanos B.   Thanopoulou A.   Drossinos V.   Charalampidou E.   Sourmeli S.   Archimandritis A.    

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 497-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus

By Pandya Bhavik J.   Bron Morgan   McCall Therese   Yu Andrew P.   Chen Kristina S.   Mattson Miles E.   Wu Eric Q.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 189-195

Informa Healthcare

Access to resources Recommend Favorite

Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial

By Umpierrez Guillermo   Issa Maher   Vlajnic Aleksandra  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 751-759

Informa Healthcare

Access to resources Recommend Favorite